The role of next-generation probiotics in obesity and obesity-associated disorders: Current knowledge and future perspectives

NG Vallianou, D Kounatidis, D Tsilingiris… - International Journal of …, 2023 - mdpi.com
Obesity and obesity-associated disorders pose a major public health issue worldwide. Apart
from conventional weight loss drugs, next-generation probiotics (NGPs) seem to be very …

Emerging role of aging in the progression of NAFLD to HCC

Y He, Y Su, C Duan, S Wang, W He, Y Zhang… - Ageing Research …, 2023 - Elsevier
With the aging of global population, the incidence of nonalcoholic fatty liver disease
(NAFLD) has surged in recent decades. NAFLD is a multifactorial disease that follows a …

The firmicutes/bacteroidetes ratio as a risk factor of breast cancer

J An, H Kwon, YJ Kim - Journal of Clinical Medicine, 2023 - mdpi.com
The gut microbiome can reflect the health condition of the entire body. Firmicutes and
Bacteroidetes, the major phyla of the colon, can influence diseases related to obesity which …

Risk stratification and early detection biomarkers for precision HCC screening

YT Lee, N Fujiwara, JD Yang, Y Hoshida - Hepatology, 2023 - journals.lww.com
Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

Immunotherapy in head and neck cancer: where do we stand?

NG Vallianou, A Evangelopoulos, D Kounatidis… - Current Oncology …, 2023 - Springer
Abstract Purposeof Review Head and neck cancer (HNC) comprises a group of
malignancies, amongst which squamous cell carcinoma accounts for more than 90% of the …

Thioredoxin/glutaredoxin systems and gut microbiota in NAFLD: interplay, mechanism, and therapeutical potential

M Zhu, OMA Dagah, BB Silaa, J Lu - Antioxidants, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a common clinical disease, and its
pathogenesis is closely linked to oxidative stress and gut microbiota dysbiosis. Recently …

Prebiotics and probiotics: Therapeutic tools for nonalcoholic fatty liver disease

A Mijangos-Trejo, N Nuño-Lambarri… - International Journal of …, 2023 - mdpi.com
Alterations in the gut–liver axis and changes in the gut microbiome are among the risk
factors for the pathogenesis of non-alcoholic fatty liver disease (NAFLD). These patients …

[HTML][HTML] Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism

X Huang, Q Chen, Y Fan, R Yang, G Gong… - Biomedicine & …, 2023 - Elsevier
Background Nonalcoholic fatty liver disease (NAFLD) is a common liver disease highly
associated with metabolic diseases and gut dysbiosis. Several clinical trials have confirmed …

Gut microbiota and bacterial translocation in the pathogenesis of liver fibrosis

R Maslennikov, E Poluektova, O Zolnikova… - International journal of …, 2023 - mdpi.com
Cirrhosis is the end result of liver fibrosis in chronic liver diseases. Studying the mechanisms
of its development and developing measures to slow down and regress it based on this …

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis

AM Gómez-Pérez, P Ruiz-Limón, J Salas-Salvadó… - Gut …, 2023 - Taylor & Francis
To evaluate the changes in the gut microbiota associated with changes in the biochemical
markers of nonalcoholic fatty liver disease (NAFLD) after a lifestyle intervention with the …